What is compounding?
Drug compounding is often regarded as the process of combining or mixing drugs to create a medication tailored to the needs of an individual patient.
The generic form of Vetmedin is Pimobendan.
Vetmedin is in limited supply. Orders placed will be shipped as product continues to come off backorder.
This item is currently out of stock. Semintra will be back-in-stock the first week of February. Orders placed will be shipped as the product comes in.
Semintra Oral Solution for Cats is an FDA-approved treatment for hypertension in felines. Hypertension is most commonly found in older cats and can affect multiple body parts including the eyes, heart and vascular system, brain and kidney and is often difficult to diagnose. While finding out your kitty has hypertension can be stressful, Semintra helps make the treatment process simple with an easy-to-use syringe and a liquid medication that's easy to administer directly into her mouth or on top of her favorite food.
Semintra (telmisartan oral solution) is a clear, colorless to yellowish viscous solution containing 10 mg/mL telmisartan. Telmisartan is an orally active, non-peptide, selective angiotensin II subtype 1 (AT1) receptor blocker, which helps control hypertension.
SEMINTRA is indicated for the control of systemic hypertension in cats.
Always providethe Client Information Sheet with each prescription.
A silent disease
While hypertension can be a common problem in older cats, the condition can be difficult to diagnose.
Hypertension can affect many parts of the body before detection and is strongly associated with target organ damage.
Without treatment, this silent disease can lead to serious illness and, sometimes, death.
Most often develops as secondary hypertension to diseases such as CKD and hyperthyroidism.
Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Always provide the Client Information Sheet with each prescription and review it with the cat owner. Advise cat owners that adverse reactions can occur with use of SEMINTRA. The most common adverse reactions reported during the field studies included vomiting, diarrhea, lethargy, weight loss, anemia and dehydration.
Do not use in cats with a hypersensitivity to telmisartan.
Not for human use. Keep out of reach of children.
SEMINTRA is an angiotensin II antagonist/angiotensin receptor blocker (ARB). Pregnant women should avoid contact with SEMINTRA because substances that act on the renin-angiotensin-aldosterone system (RAAS) such as angiotensin receptor blockers (ARBs) can cause fetal and neonatal morbidity and death during pregnancy in humans.
SEMINTRA has not been evaluated in cats with systolic blood pressure >200 mm Hg.
SEMINTRA can cause mild anemia or nonregenerative anemia. Cats should be monitored for anemia when initiating treatment with SEMINTRA.
SEMINTRA may cause inappetence and weight loss in some cats. Cats should be monitored for weight loss when initiating treatment with SEMINTRA. Use with caution in cats with a history of vomiting, inappetence or weight loss.
The safe use of SEMINTRA in cats with hepatic disease has not been evaluated. SEMINTRA is metabolized by the liver.
The safe use of SEMINTRA has not been evaluated in cats less than 9 months of age.
The safe use of SEMINTRA has not been evaluated in cats that are pregnant, lactating, or intended for breeding. See Human Warnings.
The safe use with other anti-hypertensive medications has not been evaluated.
Store at or below 25°C (77°F) with excursions permitted up to 40°C (104°F). Once the bottle is opened, use the contents within six months.